Top Markets
Coin of the day
GH Research PLC GH Research PLC

GH Research PLC

GHRS
주식 순위 #6594
GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to... GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to creating novel therapies for psychiatric and neurological conditions. The company primarily concentrates on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) treatments, specifically targeting patients with treatment-resistant depression (TRD). Its most advanced program is GH001, an inhalable 5-MeO-DMT product candidate that has successfully completed two Phase 1 clinical trials and a subsequent Phase 1/2 clinical trial in TRD patients. Additionally, GH Research is developing GH002, an injectable 5-MeO-DMT candidate, and GH003, an intranasal 5-MeO-DMT candidate. Both GH002 and GH003 are currently in preclinical development, with a focus on their potential applications in various psychiatric and neurological disorders. Founded in 2018, GH Research PLC is headquartered in Dublin, Ireland.
주가
$28.53
시가총액
$1.96B
변동 (1일)
-1.65%
변동 (1년)
109.32%
국가
IE
거래 GH Research PLC (GHRS)

카테고리

GH Research PLC (GHRS)의 주가 이력
최고 종가: $29.28 (2026-08-01 기준)

최저 종가: $20.43 (2021-06-01 기준)
GH Research PLC의 주가 이력 (2021 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 34.51%
2025 71.80%
2024 35.29%
2023 -44.18%
2022 -56.09%
2021 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$548.36 40.94%
US
$1.06K 49.46%
NL
$122.63 -12.65%
AU
$140.81 461.00%
US
$765.25 7.19%
CH